References
- Tomioka S, Kobayashi T, Takasaka T. Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media). In Sanna M, editor. Cholesteatoma and mastoid surgery. Rome: CIC Edizioni Internazionali. 1997. p 851–3.
- Derlacki EL. Aural manifestations of allergy. Ann Otol Rhinol Laryngol 1952;6:179–88.
- Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx 2011;38:456–61.
- Tomioka S, Yuasa R, Iino Y. 1993. Intractable otitis media in cases with bronchial asthma. Recent advances in otitis media. In Mogi G, Honjo I, Ishii T, Takasaka T, editors. Proceedings of the second extraordinary international symposium on recent advances on otitis media. Amsterdam: Kugler Publications, Inc. p 183–6.
- Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T. Clinical characteristics of so called eosinophilic otitis media. Auris Nasus Larynx 2002;29:19–28.
- Nakagawa T, Matsubara A, Shiratsuchi H, Kakazu Y, Nakashima T, Koike K. Intractable otitis media with eosinophils: importance of diagnosis and validity of treatment for hearing preservation. ORL J Otorhinolaryngol Relat Spec 2006;68:118–22.
- Iwasaki S, Nagura M, Mizuta K. Cochlear implantation in a patient with eosinophilic otitis media. Eur Arch Otorhinolaryngol 2006;263:365–9.
- Iino Y, Nagamine H, Yabe T, Matsutani S. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 2001;31:1135–43.
- Nonaka M, Fukumoto A, Ozu C, Mokuno E, Baba S, Pawankar R, et al. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol 2003;123:383–7.
- Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy 2005;35:1370–6.
- Nishizawa H, Matsubara A, Nakagawa T, Ohta N, Izuhara K, Shirasaki T, et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol 2012;132:838–44.
- Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma. Otol Neurotol 2008;29:949–52.
- Ryan AF, Catanzaro A, Wasserman SI, Harris JP. Secondary immune response in the middle ear: immunological, morphological, and physiological observations. Ann Otol Rhinol Laryngol 1986;95:242–9.
- Tomonaga K, Chaen T, Kurono Y, Mogi G. Type I allergic reactions of the middle ear and eustachian tube: an experimental study. Auris Nasus Larynx 1990;17:121–31.
- Juhn SK, Hamaguchi Y, Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol Suppl 1988;457:43–8.
- Lee SH, Woo HW, Jung TTK, Lee C, Miller SK, Park YM, et al. Permeability of arachidonic acid metabolites through the round window membrane in chinchillas. Acta Otolaryngol Suppl 1992;493:165–9.
- Walsh GM. Eosinophil granule proteins and their role in disease. Curr Opin Hematol 2001;8:28–33.
- Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, et al. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol 2006;97:761–6.
- Matsubara A, Kuroda R, Usami S, Takahata J, Shinkawa H. 2001. The effect of topical administration of heparin to the eosinophilic otitis media. In Takasaka T, Yuasa R, Hozawa K, editors. Recent advances in otitis media. Bologna: Monduzzi Editore. p 403–6.
- Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media. Otol Neurotol 2012;33:1218–24.